Technology

Patients increasingly arrive having read about specific devices or platforms and want to know whether the clinic uses them, what the protocol looks like, and how the device sits inside a plan. The technology hub maps the device families used at DDC, explains what each tool answers clinically, and frames technology as a calibrated tool inside a doctor-led plan rather than a brand-led promise. Reading this hub helps a patient have a more informed consultation and reduces the gap between marketing-led expectations and clinical realism. The framework is "what answers what" rather than "what is the best technology"; suitability and diagnosis drive the answer.

Most energy-based devices originate in markets where the dominant patient population is Fitzpatrick I–III; default settings, recovery protocols, and timing assumptions are calibrated against that population. Indian-skin patients (Fitzpatrick III–V) have higher melanin, more PIH risk after thermal injury, and slower recovery in friction-prone body areas. Settings calibrated for lighter skin produce more PIH, more recovery downtime, and sometimes worse long-term outcomes when applied to melanin-rich skin. The Indian-skin-first calibration uses lower fluences, longer wavelengths where applicable, longer cooling-and-recovery windows, and adjunctive PIH-management routines parallel to procedural plans. The framework keeps outcomes durable and recoveries clean.

The DDC pattern is best-fit-for-question rather than newest-on-the-market. Newer devices sometimes add genuine clinical capability and sometimes simply add brand newness; the consultation evaluates which technology answers the specific clinical question rather than chasing newness. For example, certain pigmentation work is better handled by Q-switched Nd:YAG than by newer pico platforms in selected cases; certain hair reduction work is better handled by long-pulse Nd:YAG than by diode in melanin-rich skin types. The reasoning is described at consultation. Patients who specifically want a newer platform are told whether it is the right answer for their case rather than being routed into it by default.

A test-patch is a small calibration session on a discreet area before the first full procedural session. The clinician records device, applicator, fluence/depth, and timing; the area is followed up over a defined interval (typically 1-2 weeks) to confirm no unexpected reactivity, no PIH, and clean tolerance. Once the test-patch confirms the protocol is safe for that specific patient, the first full session is scheduled. Test-patches are used selectively — they add a session and time to the plan, but in pigmentation-reactive Indian-skin patients undergoing certain protocols (fractional resurfacing, certain RF/HIFU body work), the trade-off is consistently in the patient's favour.

Multi-month plans depend on accurate baseline-to-follow-up comparison; memory is unreliable across that timescale. Standardised photography (consistent lighting, distance, and angle) at baseline and at scheduled intervals lets the patient see the trajectory honestly and lets the clinician adjust the next session against documented data rather than impression. Photography is also a protective audit trail for both sides — patients have evidence of starting state and progress, and the clinic has documentation that procedural decisions were calibrated to actual presentation. Patients who decline photography continue to receive care; the framework is transparent about why photography is the default rather than coercive.

Yes, and most patients under-discuss this with their clinic. Single-use applicators where designed for single-use, autoclave sterilisation cycles for reusable instruments, infection-control protocols for shared equipment, and documented protocols for procedure rooms differ measurably between clinics. The DDC operations layer treats sterilisation as part of the standard rather than as an add-on; protocols are documented and the staff training cadence is on a structured schedule. Patients who ask about sterilisation receive a direct answer; the framework treats this as a fair question rather than as an unusual request.

Yes. Parameter logs (device, settings, applicator, fluence/depth, session dates) and progress photographs are the patient's record. Patients who move cities, who wish to seek a second opinion, or who want to continue treatment with another dermatologist receive their data. Transparency on the audit trail is part of the operating standard at DDC; the framework treats the parameter log as belonging to the patient rather than to the clinic. Continuity of care across cities is more reliable when the receiving clinician has the actual parameter history rather than a verbal summary.

The honest answer is: the technology is selected after the diagnosis, not before. The consultation establishes diagnosis (via examination, imaging where indicated, and history); the plan then matches diagnosis to the right tool. Patients who arrive with a specific technology in mind are told whether it is the right answer for their case; the consultation may confirm the choice, suggest a different tool, or recommend a combination. The framework prevents technology being chosen as the starting point and the diagnosis being reverse-engineered to fit it. Reading this technology hub before consultation helps patients understand the broader landscape; the consultation maps the specific question to the specific tool.